Zobrazeno 1 - 10
of 47
pro vyhledávání: '"TL Kauf"'
Publikováno v:
Value in Health. 10(3)
Publikováno v:
Value in Health. 12:A422-A423
Publikováno v:
Value in Health. 11:A258-A259
Publikováno v:
Value in Health. 12:A395
Publikováno v:
Value in Health. 10:A161
Publikováno v:
Value in Health. 1(1):85-86
The choice of data used in decision modeling of health care interventions divides analysis into two groups: those who favor randomized clinical trial (RCT) data and those who prefer “real world” data. This decision may have serious consequences i
Publikováno v:
Value in Health. (3):A157-A158
Publikováno v:
Value in Health. (7):A430
Publikováno v:
Value in Health. (1):59
EPO was approved for the treatment of anemia in renal dialysis patients in 1989. In 1991, Medicare changed the way it reimbursed for EPO, and, in response, there was an increase in average EPO dosages from 2,793 units to 3,200 units in the six-month
Autor:
Levine AA; The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA., Panzer AD; The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA., Kauf TL; HEOR, Alkermes, Inc., Waltham, MA., O'Sullivan AK; Ontada, Newburyport, MA., Strand L; HEOR, Alkermes, Inc., Waltham, MA., Chambers JD; The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Jun; Vol. 29 (6), pp. 607-613.